The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy

The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance.

Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.

• Fosters a comprehensive understanding of the microbiome's role in cancer treatment, encouraging collaboration among researchers and healthcare professionals to develop holistic and innovative therapeutic strategies
• Provides practical insights into microbiome-based strategies to overcome chemoresistance, such as the use of probiotics and prebiotics in cancer therapy
• Explores how modulating the gut microbiome can enhance the efficacy of immunotherapies, offering actionable knowledge for the development of personalized and more effective cancer treatments

Dr. Aggarwal is currently a senior postdoctoral fellow at the MD Anderson Cancer Center, Texas, USA. She completed Ph.D. from AIIMS, New Delhi under supervision of Prof. S. N. Das. During PhD, wherein she successfully addressed various aspects of local immunopathology in oral squamous cell carcinoma (OSCC). She published dozens of articles and several book chapters. She is an editorial board member of several indexed reputed international journals.

Garima Malik is Assistant Professor in the Department of Pharmaceutics at M.M. College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, India. Her research focuses on nanotechnology, hydrogels, and biomaterials, and their application in drug delivery. She has contributed research articles, book chapters, and a patent, and previously worked in quality control in the pharmaceutical industry.

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.

Meenakshi Dhanawat is Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, India. Her research spans medicinal chemistry, synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, complexation, polymer chemistry, and herbal drug extraction, with a particular focus on central nervous system drug delivery. She is a recipient of the Rajiv Gandhi National Fellowship.